Skip to main content
Top
Published in: Maxillofacial Plastic and Reconstructive Surgery 1/2017

Open Access 01-12-2017 | Research

Evaluation of bone healing using rhBMP-2 soaked hydroxyapatite in ridge augmentation: a prospective observational study

Authors: Hyun-Suk Kim, Ju-Cheol Park, Pil-Young Yun, Young-Kyun Kim

Published in: Maxillofacial Plastic and Reconstructive Surgery | Issue 1/2017

Login to get access

Abstract

Background

The goal of this study is to evaluate complication and effectiveness of alveolar ridge augmentations using a hydroxyapatite-based alloplastic bony substitute with rhBMP-2.

Methods

A total of 10 patients (4 males, 6 females; 58.5 ± 8.6 years) participated in this clinical research. Alveolar ridge augmentations were performed in edentulous (4 maxillary posterior, 5 mandibular posterior, and 1 mandibular anterior) regions. Anorganic bovine bone (ABB; Bio-Oss®, Geistlich Pharma AG, Wolhusen, Switzerland) was used as the bone graft material in the control group (n = 5)) while hydroxyapatite-based alloplastic bony substitute with rhBMP-2(HA+rhBMP-2; NOVOSIS®-Dent, CGBio Inc., Seongnam, Korea) was used in the experimental group (n = 5). In order to evaluate relative changes in bone volume and resorption rate of the bone graft material, CBCT radiographs were taken immediately and at 4 months after the bone graft in all subjects. Among the 10 patients, 8 received dental implants in Seoul National University Bundang Hospital, while the others received in local clinics. Bone specimens for further histomorphometric examinations were gained from these 8 patients using trephine burs during the implant placements. Clinical, radiographic, and histomorphometric evaluations were focused because of the small sample size.

Results

When CBCT radiographs were compared between immediately and at 4.07 ± 0.13 months after the bone graft, both alveolar bone widths (ABB 2.52 ± 0.18 mm, HA+rhBMP-2 1.75 ± 0.85 mm) and heights (ABB 1.68 ± 0.17 mm, HA+rhBMP-2 1.57 ± 0.28 mm) increased in the two groups. Resorption rates of transplanted bone graft material in the alveolar bone widths and heights were (ABB 29.7 ± 8.8%, HA+rhBMP-2 31.5 ± 7.4%) and (ABB 39.2 ± 21.8%, HA+rhBMP-2 52.6 ± 6.5%), respectively. Histomorphometrically, ABB group showed bone formation via osteoconduction and HA+rhBMP-2 group via osteoinduction. HA+rhBMP-2 group showed more bone formation around the bone graft materials than the ABB group. Postoperative complications were not found in all subjects.

Conclusions

Our study had following conclusions: (1) Ridge augmentations using HA+rhBMP-2 could be clinically useful to supplement implant placements in edentulous regions. (2) Serious postoperative complications related to the graft material did not occur.
Appendix
Available only for authorised users
Literature
1.
go back to reference Park SJ, Seon HG, Koh SW, Chee YD (2012) Retrospective clinical study on marginal bone loss of implants with guided bone regeneration. Maxillofac Plast Reconstr Surg 34(6):440–448 Park SJ, Seon HG, Koh SW, Chee YD (2012) Retrospective clinical study on marginal bone loss of implants with guided bone regeneration. Maxillofac Plast Reconstr Surg 34(6):440–448
3.
go back to reference Hwang ST, Han IH, Huh JB, Kang JK, Ryu JJ (2011) Review of the developmental trend of implant surface modification using organic biomaterials. J Adv Prosthodont 49(3):254–262 Hwang ST, Han IH, Huh JB, Kang JK, Ryu JJ (2011) Review of the developmental trend of implant surface modification using organic biomaterials. J Adv Prosthodont 49(3):254–262
4.
go back to reference Um IW, Hwang SH, Kim YK, Kim MY, Jun SH, Ryu JJ, Jang HS (2016) Demineralized dentin matrix combined with recombinant human bone morphogenetic protein-2 in rabbit calvarial defects. J Korean Assoc Oral Maxillofac Surg 42(2):90–98CrossRefPubMedPubMedCentral Um IW, Hwang SH, Kim YK, Kim MY, Jun SH, Ryu JJ, Jang HS (2016) Demineralized dentin matrix combined with recombinant human bone morphogenetic protein-2 in rabbit calvarial defects. J Korean Assoc Oral Maxillofac Surg 42(2):90–98CrossRefPubMedPubMedCentral
5.
go back to reference Cheng H, Jiang W, Phillips FM, Haydon RC, Peng Y, Zhou L, Szatkowski JP (2003) Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). J Bone Joint Surg Am 85(8):1544–1552CrossRefPubMed Cheng H, Jiang W, Phillips FM, Haydon RC, Peng Y, Zhou L, Szatkowski JP (2003) Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). J Bone Joint Surg Am 85(8):1544–1552CrossRefPubMed
6.
go back to reference Boyne PJ, Marx RE, Nevins M, Triplett G, Lazaro E, Lilly LC, Nummikoski P (1997) A feasibility study evaluating rhBMP-2/absorbable collagen sponge for maxillary sinus floor augmentation. Int J Periodontics Restorative Dent 17(1):11–25PubMed Boyne PJ, Marx RE, Nevins M, Triplett G, Lazaro E, Lilly LC, Nummikoski P (1997) A feasibility study evaluating rhBMP-2/absorbable collagen sponge for maxillary sinus floor augmentation. Int J Periodontics Restorative Dent 17(1):11–25PubMed
7.
go back to reference Kim HJ, Chung JH, Shin SY, Shin SI, Kye SB, Kim NK, Kook MS (2015) Efficacy of rhBMP-2/hydroxyapatite on sinus floor augmentation: a multicenter, randomized controlled clinical trial. J Dent Res 94(suppl):158S–165SCrossRefPubMed Kim HJ, Chung JH, Shin SY, Shin SI, Kye SB, Kim NK, Kook MS (2015) Efficacy of rhBMP-2/hydroxyapatite on sinus floor augmentation: a multicenter, randomized controlled clinical trial. J Dent Res 94(suppl):158S–165SCrossRefPubMed
8.
go back to reference Hanisch O, Tatakis DN, Boskovic MM, Rohrer MD, Wikesjö UM (1997) Bone formation and re-osseointegration in peri-implantitis defects following surgical implantation of rhBMP-2. Int J Oral Maxillofac Implants 12(5):604–610PubMed Hanisch O, Tatakis DN, Boskovic MM, Rohrer MD, Wikesjö UM (1997) Bone formation and re-osseointegration in peri-implantitis defects following surgical implantation of rhBMP-2. Int J Oral Maxillofac Implants 12(5):604–610PubMed
9.
go back to reference Howell TH, Fiorellini J, Jones A, Alder M, Nummikoski P, Lazaro M, Cochran D (1997) A feasibility study evaluating rhBMP-2/absorbable collagen sponge device for local alveolar ridge preservation or augmentation. Int J Periodontics Restorative Dent 17(2):125–139 Howell TH, Fiorellini J, Jones A, Alder M, Nummikoski P, Lazaro M, Cochran D (1997) A feasibility study evaluating rhBMP-2/absorbable collagen sponge device for local alveolar ridge preservation or augmentation. Int J Periodontics Restorative Dent 17(2):125–139
10.
go back to reference Sigurdsson TJ, Nygaard L, Tatakis DN, Fu E, Turek TJ, Jin L, Wikesjö UM (1996) Periodontal repair in dogs: evaluation of rhBMP-2 carriers. Int J Periodontics Restorative Dent 16(6):525–537 Sigurdsson TJ, Nygaard L, Tatakis DN, Fu E, Turek TJ, Jin L, Wikesjö UM (1996) Periodontal repair in dogs: evaluation of rhBMP-2 carriers. Int J Periodontics Restorative Dent 16(6):525–537
11.
go back to reference Ike M, Urist MR (1998) Recycled dentin root matrix for a carrier of recombinant human bone morphogenetic protein. J Oral Implantol 24(3):124–132CrossRefPubMed Ike M, Urist MR (1998) Recycled dentin root matrix for a carrier of recombinant human bone morphogenetic protein. J Oral Implantol 24(3):124–132CrossRefPubMed
12.
go back to reference Jung RE, Glauser R, Schärer P, Hämmerle CH, Sailer HF, Weber FE (2003) Effect of rhBMP-2 on guided bone regeneration in humans. Clin Oral Implants Res 14(5):556–568CrossRefPubMed Jung RE, Glauser R, Schärer P, Hämmerle CH, Sailer HF, Weber FE (2003) Effect of rhBMP-2 on guided bone regeneration in humans. Clin Oral Implants Res 14(5):556–568CrossRefPubMed
13.
go back to reference Kim YK, Um IW, An HJ, Kim KW, Hong KS, Murata M (2014) Effects of demineralized dentin matrix used as an rhBMP-2 carrier for bone regeneration. J Hard Tissue Biol 23(4):415–422CrossRef Kim YK, Um IW, An HJ, Kim KW, Hong KS, Murata M (2014) Effects of demineralized dentin matrix used as an rhBMP-2 carrier for bone regeneration. J Hard Tissue Biol 23(4):415–422CrossRef
14.
go back to reference Asahina I (2014) Bone morphogenetic proteins: their history and characteristics. J Hard Tissue Biol 23(3):283–286CrossRef Asahina I (2014) Bone morphogenetic proteins: their history and characteristics. J Hard Tissue Biol 23(3):283–286CrossRef
15.
go back to reference Bessho K, Tagawa T, Murata M (1989) Purification of bone morphogenetic protein derived from bovine bone matrix. Biochem Biophys Res Commun 165(2):595–601CrossRefPubMed Bessho K, Tagawa T, Murata M (1989) Purification of bone morphogenetic protein derived from bovine bone matrix. Biochem Biophys Res Commun 165(2):595–601CrossRefPubMed
16.
go back to reference Sato K, Urist MR (1985) Induced regeneration of calvaria by bone morphogenetic protein (BMP) in dogs. Clin Orthop Relat Res 197:301–311 Sato K, Urist MR (1985) Induced regeneration of calvaria by bone morphogenetic protein (BMP) in dogs. Clin Orthop Relat Res 197:301–311
17.
go back to reference Hwang DY, On SW, Song SI (2016) Bone regenerative effect of recombinant human bone morphogenetic protein-2 after cyst enucleation. Maxillofac Plast Reconstr Surg 38(1):1–6CrossRef Hwang DY, On SW, Song SI (2016) Bone regenerative effect of recombinant human bone morphogenetic protein-2 after cyst enucleation. Maxillofac Plast Reconstr Surg 38(1):1–6CrossRef
18.
go back to reference Geiger M, Li RH, Friess W (2003) Collagen sponges for bone regeneration with rhBMP-2. Adv Drug Deliv Rev 55(12):1613–1629CrossRefPubMed Geiger M, Li RH, Friess W (2003) Collagen sponges for bone regeneration with rhBMP-2. Adv Drug Deliv Rev 55(12):1613–1629CrossRefPubMed
19.
go back to reference Kim YK (2014) Bone graft using two types of scaffolds and recombinant human bone morphogenetic protein-2: case series study. Oral Biology Research 38(2):127–134CrossRef Kim YK (2014) Bone graft using two types of scaffolds and recombinant human bone morphogenetic protein-2: case series study. Oral Biology Research 38(2):127–134CrossRef
20.
go back to reference Burkus JK, Gornet MF, Glassman SD, Slosar PJ, Rosner MK, Deckey JE, Hatcher BM (2011) Blood serum antibody analysis and long-term follow-up of patients treated with recombinant human bone morphogenetic protein-2 in the lumbar spine. Spine 36(25):2158–2167CrossRefPubMed Burkus JK, Gornet MF, Glassman SD, Slosar PJ, Rosner MK, Deckey JE, Hatcher BM (2011) Blood serum antibody analysis and long-term follow-up of patients treated with recombinant human bone morphogenetic protein-2 in the lumbar spine. Spine 36(25):2158–2167CrossRefPubMed
21.
go back to reference Mines D, Gu Y, Kou TD, Cooper GS (2011) Recombinant human bone morphogenetic protein-2 and pancreatic cancer: a retrospective cohort study. Pharmacoepidemiol Drug Saf 20(2):111–118CrossRefPubMed Mines D, Gu Y, Kou TD, Cooper GS (2011) Recombinant human bone morphogenetic protein-2 and pancreatic cancer: a retrospective cohort study. Pharmacoepidemiol Drug Saf 20(2):111–118CrossRefPubMed
22.
go back to reference Cooper GS, Kou TD (2013) Risk of cancer after lumbar fusion surgery with recombinant human bone morphogenic protein-2 (rh-BMP-2). Spine 38(21): 1862-1868 Cooper GS, Kou TD (2013) Risk of cancer after lumbar fusion surgery with recombinant human bone morphogenic protein-2 (rh-BMP-2). Spine 38(21): 1862-1868
23.
go back to reference Zara JN, Siu RK, Zhang X, Shen J, Ngo R, Lee M, Wu BM (2011) High doses of bone morphogenetic protein 2 induce structurally abnormal bone and inflammation in vivo. Tissue Eng Part A 17(9–10):1389–1399CrossRefPubMedPubMedCentral Zara JN, Siu RK, Zhang X, Shen J, Ngo R, Lee M, Wu BM (2011) High doses of bone morphogenetic protein 2 induce structurally abnormal bone and inflammation in vivo. Tissue Eng Part A 17(9–10):1389–1399CrossRefPubMedPubMedCentral
24.
go back to reference Wong DA, Kumar A, Jatana S, Ghiselli G, Wong K (2008) Neurologic impairment from ectopic bone in the lumbar canal: a potential complication of off-label PLIF/TLIF use of bone morphogenetic protein-2 (BMP-2). Spine J 8(6):1011–1018CrossRefPubMed Wong DA, Kumar A, Jatana S, Ghiselli G, Wong K (2008) Neurologic impairment from ectopic bone in the lumbar canal: a potential complication of off-label PLIF/TLIF use of bone morphogenetic protein-2 (BMP-2). Spine J 8(6):1011–1018CrossRefPubMed
25.
go back to reference Murata M, Um IW (2014) Advances in oral tissue engineering. Quintessence, Illinois Murata M, Um IW (2014) Advances in oral tissue engineering. Quintessence, Illinois
Metadata
Title
Evaluation of bone healing using rhBMP-2 soaked hydroxyapatite in ridge augmentation: a prospective observational study
Authors
Hyun-Suk Kim
Ju-Cheol Park
Pil-Young Yun
Young-Kyun Kim
Publication date
01-12-2017
Publisher
Springer Berlin Heidelberg
Published in
Maxillofacial Plastic and Reconstructive Surgery / Issue 1/2017
Electronic ISSN: 2288-8586
DOI
https://doi.org/10.1186/s40902-017-0138-9

Other articles of this Issue 1/2017

Maxillofacial Plastic and Reconstructive Surgery 1/2017 Go to the issue